By Counterforce Health Team in Opsumit (macitentan) —

Myths vs. Facts: Getting Opsumit (macitentan) Covered by Aetna (CVS Health) in Ohio

Answer Box: Getting Opsumit (macitentan) Covered by Aetna (CVS Health) in Ohio

Eligibility: Aetna requires prior authorization for all Opsumit requests with WHO Group 1 PAH diagnosis and specialist prescription. Fastest Path: Submit PA through Aetna provider portal with right heart catheterization results, WHO functional class II-III documentation, and pregnancy testing compliance. First Step Today: Call Aetna Member Services at 1-866-814-5506 to verify current PA requirements and obtain forms. Standard decisions take 30-45 days; expedited urgent requests receive decisions within 72 hours maximum.

Table of Contents

  1. Why Myths About Opsumit Coverage Persist
  2. Common Myths vs. Facts
  3. What Actually Influences Approval
  4. Avoid These Critical Mistakes
  5. Quick Action Plan: Three Steps Today
  6. Ohio-Specific Appeal Rights
  7. Resources and Forms

Why Myths About Opsumit Coverage Persist

Misinformation about getting Opsumit (macitentan) covered by Aetna spreads easily because pulmonary arterial hypertension is a rare disease affecting fewer than 200,000 Americans. Many patients and even some healthcare providers haven't navigated the specialty drug approval process before. The complexity of Aetna's requirements, combined with recent changes to the FDA's REMS program discontinuation in April 2025, creates confusion about what's actually required for coverage.

Additionally, Ohio's insurance landscape—where Anthem holds about 31% market share alongside other major carriers—means patients often confuse requirements across different insurers. Let's separate fact from fiction.

Common Myths vs. Facts

Myth 1: "If my cardiologist prescribes Opsumit, Aetna has to cover it immediately"

Fact: Aetna requires prior authorization for all Opsumit requests, regardless of who prescribes it. The medication must be prescribed by or in consultation with a pulmonologist or cardiologist, but specialist prescription alone doesn't guarantee automatic coverage.

Myth 2: "The REMS program is still required for insurance approval"

Fact: The FDA discontinued the Opsumit REMS program on April 2, 2025. However, pregnancy testing requirements remain in effect as part of prescribing information. Female patients still need monthly pregnancy tests, but stakeholders no longer need REMS enrollment or certification.

Myth 3: "I can get Opsumit at my local pharmacy once approved"

Fact: Opsumit remains a specialty medication that must be dispensed through CVS Specialty Pharmacy only—it cannot be filled at retail locations. The medication is delivered by mail with specialty pharmacy support services.

Myth 4: "If Aetna denies my request, I'm out of options"

Fact: Ohio residents have strong appeal rights. After exhausting internal appeals with Aetna, you can request an external review through the Ohio Department of Insurance within four months. The external review decision is legally binding on Aetna.

Myth 5: "Any PAH diagnosis qualifies for Opsumit coverage"

Fact: Aetna specifically requires WHO Group 1 PAH with predominantly WHO Functional Class II-III symptoms. Other forms of pulmonary hypertension don't meet coverage criteria.

Myth 6: "I need to try other PAH medications first (step therapy)"

Fact: Aetna's 2025 specialty guidelines don't include explicit step therapy requirements for Opsumit, though individual plans may vary. The focus is on meeting WHO Group 1 PAH criteria and functional classification rather than prior medication trials.

Myth 7: "Appeals take months and rarely succeed"

Fact: Standard Aetna decisions take 30-45 days, while expedited urgent requests receive decisions within 72 hours. Ohio's external review process provides decisions within 30 days for standard reviews, with binding outcomes when medical evidence supports coverage.

What Actually Influences Approval

Understanding Aetna's actual criteria helps you submit a complete request the first time:

Core Documentation Requirements

WHO Group 1 PAH Diagnosis: Right heart catheterization results confirming pulmonary arterial hypertension, not other forms of pulmonary hypertension. Include specific hemodynamic measurements and ICD-10 diagnostic codes.

Functional Classification: WHO Functional Class II-III documentation showing symptom severity and activity limitations. Be specific about which activities trigger dyspnea, fatigue, or syncope.

Specialist Prescription: Must be prescribed by or in consultation with a pulmonologist or cardiologist. Include provider credentials and PAH expertise in the request.

Pregnancy Testing Compliance

For female patients of reproductive potential:

  • Initial negative pregnancy test before starting treatment
  • Monthly pregnancy testing during treatment
  • Documentation of reliable contraception methods
  • One month of testing after stopping treatment

Submission Process

Fastest Route: Aetna provider portal (Availity) for electronic submissions Phone: 1-866-814-5506 (specialty pharmacy line) Fax: 1-866-249-6155 (specialty requests)

Note: Authorization of 12 months may be granted when all criteria are met, with maximum approved dose of 10 mg (1 tablet) per day.

Avoid These Critical Mistakes

1. Submitting Incomplete Functional Class Documentation

Many requests fail because they lack specific WHO functional class assessment. Don't just state "Class III"—document exactly which activities cause symptoms and how this limits the patient's daily life.

2. Missing Right Heart Catheterization Results

Echocardiogram estimates aren't sufficient. Aetna requires invasive hemodynamic confirmation of WHO Group 1 PAH with specific pressure measurements and resistance calculations.

3. Using Non-Specialist Prescribers

Primary care physicians can't prescribe Opsumit for Aetna coverage. The request must come from or be co-signed by a pulmonologist or cardiologist with PAH expertise.

4. Forgetting Pregnancy Testing Documentation

Even though REMS is discontinued, pregnancy testing requirements remain. Female patients need documented negative tests and contraception plans before approval.

5. Not Requesting Expedited Review When Appropriate

If the patient's condition is deteriorating or hospitalization risk is high, request expedited review for 72-hour decision turnaround instead of waiting 30-45 days.

Quick Action Plan: Three Steps Today

Step 1: Verify Your Aetna Plan Details

Call Member Services at the number on your insurance card. Ask specifically about:

  • Current prior authorization requirements for Opsumit
  • Whether your plan uses CVS Caremark for specialty medications
  • Your specialty pharmacy copay or coinsurance amount

Step 2: Gather Required Documentation

Work with your PAH specialist to collect:

  • Right heart catheterization report with specific measurements
  • WHO functional class assessment with activity examples
  • Current pregnancy test results (if applicable)
  • Complete PAH treatment history and current medications

Step 3: Submit Through the Fastest Channel

Use the Aetna provider portal (Availity) for electronic submission, or call 1-866-814-5506 for specialty pharmacy prior authorization. Request expedited review if your condition is urgent.

Ohio-Specific Appeal Rights

Ohio residents have particularly strong consumer protections when Aetna denies Opsumit coverage:

Internal Appeal Process

You have 180 days from the denial to request an internal appeal with Aetna. Standard internal appeals receive decisions within 30 days, while expedited appeals for urgent situations receive decisions within 72 hours.

External Review Through Ohio Department of Insurance

After completing internal appeals, you can request external review within four months of Aetna's final denial. Key advantages:

  • No cost to you: Ohio covers the external review expense
  • Independent medical experts: Qualified reviewers assess your case
  • Binding decisions: If approved, Aetna must provide coverage
  • 30-day timeline: Standard external reviews conclude within 30 days

Getting Help in Ohio

  • Ohio Department of Insurance Consumer Hotline: 800-686-1526
  • UHCAN Ohio: Nonprofit advocacy for health coverage appeals
  • External Review Forms: Available at insurance.ohio.gov
From our advocates: We've seen Ohio external reviews succeed when patients provide comprehensive PAH specialist documentation showing disease progression and functional decline. The key is demonstrating that Opsumit meets FDA-approved indications and that the patient's specific clinical picture aligns with Aetna's own coverage criteria.

Resources and Forms

Official Aetna Resources

Ohio Department of Insurance

Clinical Resources

Patient Support

  • Janssen Opsumit Support: Available through specialty pharmacy
  • PAH patient advocacy organizations for additional guidance

About Counterforce Health: Counterforce Health helps patients, clinicians, and specialty pharmacies get prescription drugs approved by turning insurance denials into targeted, evidence-backed appeals. Our platform analyzes denial letters and payer policies to draft point-by-point rebuttals with the right clinical evidence and procedural requirements for each insurer.

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance coverage decisions depend on individual plan terms, clinical circumstances, and current policies. Always consult with your healthcare provider and insurance company for personalized guidance. For official Ohio insurance regulations and appeal procedures, contact the Ohio Department of Insurance directly.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.